DKSH (DKSH) CMD 2024 summary
Event summary combining transcript, slides, and related documents.
CMD 2024 summary
15 May, 2026Strategic priorities and transformation
Accelerated growth, margin expansion, and M&A are central to the midterm roadmap, building on a solid transformation since 2019 with a focus on operational excellence, digitization, and sustainability.
Diversification across Asia-Pacific, Australia, New Zealand, Europe, and North America has reduced reliance on a few markets and expanded the specialty performance business globally.
Business units pursue tailored strategies: Healthcare focuses on commercial outsourcing and own brands, Consumer Goods on profitable client mix and sales force excellence, Performance Materials on globalizing core business and value-added services, and Technology on scientific solutions and high-tech industries.
Sustainability and ESG are key differentiators, with improved ratings, a commitment to science-based targets, and net zero emissions.
Digitization and AI projects are driving efficiency, with over 60% of distribution centers digitized, digital sales up 3.5x since 2019, and >83% digital payments in 2023.
Financial performance and guidance
Core EBIT CAGR since 2019 exceeded 10%, with margin rising from 2.4% to 3% in 2023; free cash flow and asset-light model support strong cash generation.
Net sales grew at 3.3% CAGR since 2019, outperforming GDP, despite FX headwinds; mid-term ambition is net sales growth above GDP and margin expansion of at least 10 bps per year.
Working capital as a percent of net sales reduced by 170 basis points, freeing up CHF 200 million in cash; CapEx remains low at 0.4% of net sales.
Dividend has increased every year since IPO, with a commitment to progressive annual growth regardless of market conditions.
Zero net debt and equity ratio of 31.8% as of December 2023.
M&A and growth outlook
28 acquisitions since 2019, with 80% in higher-margin segments; over CHF 900M invested since 2019; ANZ EBIT rose from 1% to 10% of group EBIT in five years due to M&A.
Strongest M&A pipeline ever, with plans for more and larger deals, especially in Performance Materials and North America; leverage comfort up to 2x, temporarily 2.5x.
M&A decision-making is BU-driven, with group oversight and board approval for larger deals; integration and cultural fit are emphasized.
Business units are targeting white spots, especially in India and Europe, and focusing on bolt-on and transformational acquisitions.
M&A framework emphasizes strategic fit, margin accretion, and full integration of acquired companies.
Latest events from DKSH
- Core EBIT up 6.7% to CHF 349m, margin expands, and dividend rises 6.4% amid strong cash flow.DKSH
H2 202517 Feb 2026 - Core EBIT and net sales grew at CER, with strong cash flow and margin expansion.DKSH
H1 20243 Feb 2026 - Strong 2024 results: sales, EBIT, and margins up; robust cash flow and higher dividend.DKSH
H2 202411 Dec 2025 - Net sales up 2.1%, core EBIT up 5.1%, strong cash flow, and robust M&A pipeline in H1 2025.DKSH
H1 202513 Nov 2025